20621912

Source:http://linkedlifedata.com/resource/pubmed/id/20621912

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007222, umls-concept:C0008976, umls-concept:C0035647, umls-concept:C0282402, umls-concept:C2737276
pubmed:issue	1
pubmed:dateCreated	2010-7-12
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20621912-20157135
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, Conjugated (USP), http://linkedlifedata.com/resource/pubmed/chemical/Medroxyprogesterone Acetate
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1539-3704
pubmed:author	pubmed-author:PinesAmosA, pubmed-author:SturdeeDavidD
pubmed:issnType	Electronic
pubmed:day	6
pubmed:volume	153
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	61; author reply 61-2
pubmed:meshHeading	pubmed-meshheading:20621912-Cardiovascular Diseases, pubmed-meshheading:20621912-Data Interpretation, Statistical, pubmed-meshheading:20621912-Estrogen Replacement Therapy, pubmed-meshheading:20621912-Estrogens, Conjugated (USP), pubmed-meshheading:20621912-Female, pubmed-meshheading:20621912-Humans, pubmed-meshheading:20621912-Medroxyprogesterone Acetate, pubmed-meshheading:20621912-Postmenopause, pubmed-meshheading:20621912-Randomized Controlled Trials as Topic, pubmed-meshheading:20621912-Risk Factors, pubmed-meshheading:20621912-Time Factors
pubmed:year	2010
pubmed:articleTitle	Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
pubmed:publicationType	Letter, Comment